Literature DB >> 31449197

The Problematic 2014 American Academy of Pediatrics Bronchiolitis Guidelines.

Larry B Mellick1,2, Juan Gonzalez2.   

Abstract

The 2014 American Academy of Pediatrics bronchiolitis guidelines do not adequately serve the needs and clinical realities of front-line clinicians caring for undifferentiated wheezing infants and children. This article describes the clinical challenges of evaluating and managing a heterogeneous disease syndrome presenting as undifferentiated patients to the emergency department. Although the 2014 American Academy of Pediatrics bronchiolitis guidelines and the multiple international guidelines that they closely mirror have made a good faith attempt to provide clinicians with the best evidence-based recommendations possible, they have all failed to address practical, front-line clinical challenges. The therapeutic nihilism of the guidelines and the dissonance between many of the recommendations and frontline realities have had wide-ranging consequences. Nevertheless, newer evidence of therapeutic options is emerging and forecasts hope for more therapeutically optimistic recommendations with the next revision of the guidelines.

Entities:  

Mesh:

Year:  2019        PMID: 31449197     DOI: 10.1097/PEC.0000000000001915

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  2 in total

1.  Lung ultrasound to predict pediatric intensive care admission in infants with bronchiolitis (LUSBRO study).

Authors:  Sara Bobillo-Perez; Clara Sorribes; Paula Gebellí; Nuria Lledó; Marta Castilla; Miquel Ramon; Javier Rodriguez-Fanjul
Journal:  Eur J Pediatr       Date:  2021-02-13       Impact factor: 3.183

2.  Cost-effectiveness analysis of phenotypic-guided versus guidelines-guided bronchodilator therapy in viral bronchiolitis.

Authors:  Carlos E Rodriguez-Martinez; Gustavo Nino; Jose A Castro-Rodriguez; Geovanny F Perez; Monica P Sossa-Briceño; Jefferson A Buendia
Journal:  Pediatr Pulmonol       Date:  2020-10-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.